Premium
Phenytoin: Effects on Calcium Flux and Cyclic Nucleotides
Author(s) -
Ferrendelli James A.,
Kinscherf Dorothy A.
Publication year - 1977
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/j.1528-1157.1977.tb04975.x
Subject(s) - phenytoin , chemistry , calcium , depolarization , ouabain , cyclic nucleotide , sodium , anticonvulsant , potassium , synaptosome , pharmacology , medicine , nucleotide , biophysics , endocrinology , biochemistry , epilepsy , biology , neuroscience , organic chemistry , gene
SUMMARY Previous studies have demonstrated that phenytoin alters calcium conductance in isolated presynaptic nerve endings (synaptosomes) from rat or rabbit brain. Drug concentrations of 0.08 ITIM (20 μg/ml) or higher inhibit stimulated calcium influx into synaptosomes depolarized by high concentrations of potassium (69 min) by 7–58%. Calcium transport into undepolarized synaptosomes is only inhibited by 0.4 min or greater concentrations of phenytoin. Recent investigations show that in mouse brain slices, phenytoin inhibited elevations of cyclic GMP and cyclic AMP produced by ouabain or verat‐ridine. In contrast, elevations of the two cyclic nucleotides produced by high concentrations of potassium were not inhibited by phenytoin, suggesting that the anticonvulsant suppresses depolarization‐induced elevation of cyclic nucleotide levels in brain slices by inhibiting influx of sodium into cells. These data indicate that phenytoin inhibits both sodium and calcium influx into cells during cellular depolarization and alters regulation of brain cyclic nucleotide levels. Both of these actions may be important for the antiepileptic effect of phenytoin.